Soumya Chakravarty, MD, PhD, FACP, FACR, strategic lead, Rheumatology Therapeutic Area at Janssen, speaks on nontherapeutic approaches to manage symptom burden of psoriatic arthritis.
Diet, meditation, and exercise are several nontherapeutic strategies to manage symptom burden of psoriatic arthritis, said Soumya Chakravarty, MD, PhD, FACP, FACR, strategic lead, Rheumatology Therapeutic Area at Janssen.
Transcript
What are some nondrug treatment approaches that can help manage symptom burden of psoriatic arthritis?
Now, as far as the nondrug treatment approach, in terms of helping manage symptom burden, I think that's very important to consider in a disease like psoriatic arthritis, because of the elements that we've talked about. Apart from inflammation, and the sequelae of that inflammation, like pain, like fatigue, there are nondrug approaches that we can take.
That includes having a healthy diet, trying low-impact exercise, taking care of one's mental health. And we've talked about fatigue as an example of psoriatic arthritis causing that.
So, Tai Chi, meditation, telteherapy—these are all strategies that help ease fatigue over time. At the same time, patients can find some benefit in being able to join support programs, share their psoriatic arthritis experiences with other patients and families. And, of course, make sure that this management plan and the approach that's taken both from a therapeutic, but also nontherapeutic approach is individualized and personalized, because again, there's no one-size-fits-all approach here.
Each person living with psoriatic arthritis is very unique. We'll need to test out, again, different management strategies with their health care provider in that shared decision-making context to see what works best for them.
Hospital Stays and Probable Dementia as Predictors of Relocation to Long-Term Care Facilities
October 22nd 2024This article explores late-life relocations in patients with dementia, hospital stays, and their implications for health care policy, geriatric care, and future research priorities.
Read More
Sustaining Compassionate Trauma Care Across Communities
September 30th 2024September is National Recovery Month, and we are bringing you another limited-edition month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In our final episode, we speak with Lyndra Bills, MD, and Shari Hutchison, MS.
Listen
Frameworks for Advancing Health Equity: Community Wellness Centers
September 27th 2024Delia Orosco, MS, director of Community Wellness Centers at Inland Empire Health Plan, shares insight into innovative initiatives provided by the wellness centers and their new mobile mammogram clinics.
Listen
Lower Diagnostic Error Rates Found Among Hospitalized Patients During Care Transitions
October 21st 2024Examining care transitions in hospitalized patients revealed lower diagnostic error rates compared with traditional methods, highlighting the effectiveness of this approach in identifying diagnostic challenges.
Read More
FLT3 Inhibitor Gilteritinib May Also Be Effective as ALK Inhibitor in AML
October 20th 2024The case study, which showed prolonged disease control achieved with gilteritinib in a previously-treated patient with AML with an inv(2)(p23q13) translocation, indicates that gilteritinib can also be used as an anaplastic lymphoma kinase (ALK) inhibitor.
Read More